Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D. Tormo N, et al. Among authors: remigia mj. Bone Marrow Transplant. 2010 Mar;45(3):543-9. doi: 10.1038/bmt.2009.172. Epub 2009 Jul 20. Bone Marrow Transplant. 2010. PMID: 19617905
Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution.
de la Rubia J, Cantero S, Sanz GF, Remigia MJ, Monteagudo E, Moscardó F, Martín G, Lorenzo I, Jiménez C, Martínez J, Montesinos P, Jarque I, Sanz MA. de la Rubia J, et al. Among authors: remigia mj. Bone Marrow Transplant. 2005 Aug;36(4):325-9. doi: 10.1038/sj.bmt.1705067. Bone Marrow Transplant. 2005. PMID: 15968276 Clinical Trial.
Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.
Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, Hernández-Boluda JC, Remigia MJ, Jarque I, Calabuig ML, Garcia-Noblejas A, Alberola J, Tamarit A, Gimeno C, Navarro D. Solano C, et al. Among authors: remigia mj. Haematologica. 2008 Sep;93(9):1434-6. doi: 10.3324/haematol.12880. Epub 2008 Jul 4. Haematologica. 2008. PMID: 18603553 Free article. No abstract available.
Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.
Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D. Gimeno C, et al. Among authors: remigia mj. J Clin Microbiol. 2008 Oct;46(10):3311-8. doi: 10.1128/JCM.00797-08. Epub 2008 Aug 27. J Clin Microbiol. 2008. PMID: 18753357 Free PMC article.
An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
Tormo N, Solano C, de la Cámara R, Garcia-Noblejas A, Cardeñoso L, Clari MA, Nieto J, López J, Hernández-Boluda JC, Remigia MJ, Benet I, Navarro D. Tormo N, et al. Among authors: remigia mj. Biol Blood Marrow Transplant. 2010 May;16(5):653-61. doi: 10.1016/j.bbmt.2009.12.003. Epub 2010 Jan 29. Biol Blood Marrow Transplant. 2010. PMID: 20005968 Free article.
Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, Garcia-Noblejas A, Clari MA, Chilet M, López J, Hernández-Boluda JC, Remigia MJ, Navarro D. Tormo N, et al. Among authors: remigia mj. J Med Virol. 2010 Jul;82(7):1208-15. doi: 10.1002/jmv.21799. J Med Virol. 2010. PMID: 20513086
Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection.
Muñoz-Cobo B, Solano C, Nieto J, de la Cámara R, Remigia MJ, Garcia-Noblejas A, López J, Benet I, Hernández-Boluda JC, Costa E, Bravo D, Navarro D. Muñoz-Cobo B, et al. Among authors: remigia mj. Bone Marrow Transplant. 2011 Nov;46(11):1484-6. doi: 10.1038/bmt.2010.322. Epub 2011 Jan 10. Bone Marrow Transplant. 2011. PMID: 21217790 No abstract available.
Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D. Tormo N, et al. Among authors: remigia mj. Bone Marrow Transplant. 2011 Nov;46(11):1437-43. doi: 10.1038/bmt.2010.330. Epub 2011 Jan 17. Bone Marrow Transplant. 2011. PMID: 21243030
Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recipients.
Solano C, Tormo N, de la Cámara R, Bartolo Nieto J, López J, Benet I, Muñoz-Cobo B, Costa E, Remigia MJ, Garcia-Noblejas A, Bravo D, Navarro D. Solano C, et al. Among authors: remigia mj. Clin Infect Dis. 2011 Aug 1;53(3):313-5; author reply 315-6. doi: 10.1093/cid/cir414. Clin Infect Dis. 2011. PMID: 21765090 No abstract available.
Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.
Solano C, Benet I, Remigia MJ, de la Cámara R, Muñoz-Cobo B, Costa E, Clari MÁ, Bravo D, Amat P, Navarro D. Solano C, et al. Among authors: remigia mj. Transplantation. 2011 Aug 27;92(4):e17-20. doi: 10.1097/TP.0b013e318224f263. Transplantation. 2011. PMID: 21814124 No abstract available.
41 results